Table 4. Antibiotic therapy for pyomyositis.
| Disease classification | Antibiotic | Adult dose |
|---|---|---|
| Empirical therapy | Ampicillin/sulbactam or | 3 g q6 h IV |
| cefepime or | 2 g q8 h IV | |
| piperacillin/tazobactam or | 3.375–4.5 g q6–8 h IV | |
| ertapenem | 1 g q24 h IV | |
| Streptococcus | Penicillin | 2–4 million units q4–6 h IV |
| Plus | ||
| clindamycin | 600–900 mg q8 h IV | |
| Methicillin-susceptible S. aureus | Nafcillin or | 1–2 g q4 h IV |
| cefazolin | 1–2 g q8 h IV | |
| Methicillin-resistance S. aureus | Vancomycin or | 15 mg/kg q12 h IV |
| teicoplanin or | 6–12 mg/kg q24 h IV | |
| linezolid | 600 mg q12 h IV |
IV, intravenous; PO, per os.